Last deal

$673.48K
Local Amount - SEK 7M

Amount

Convertible Note

Stage

29.03.2023

Date

3

all rounds

$21.14M

Total amount

date founded

Financing round

General

About Company
Modus Therapeutics develops pharmaceutical therapies to restore impaired blood flow in rare diseases.

Industry

Sector :

Subsector :

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Convertible Note

IPO status

Private

Description

Modus Therapeutics, a clinical-stage drug development company based in Stockholm, Sweden, focuses on developing adjunctive therapy to anti-parasite medicines to prevent infected red blood cells from obstructing blood vessels. The company, formerly known as Dilaforette, changed its name to Modus Therapeutics in October 2016. With a near-term focus on developing sevuparin for patients with sepsis/septic shock, Modus Therapeutics aims to address high unmet medical needs and potentially reduce mortality rates while saving healthcare costs.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Anelixis Therapeutics

Anelixis Therapeutics

Anelixis Therapeutics is a biotech company that helps develop drugs for neurodegenerative diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Cambridge, MA, USA

total rounds

2

total raised

$6.86M
Applied Therapeutics

Applied Therapeutics

Applied Therapeutics develops novel drugs for patients with high unmet medical needs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

New York, NY, USA

total rounds

8

total raised

$419.07M
Enalare Therapeutics

Enalare Therapeutics

Enalare Therapeutics Inc. develops and commercializes novel therapies for acute respiratory and critical care conditions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Therapeutics

Location

Naples, FL, USA

total rounds

6

total raised

$73.85M
Acer Therapeutics

Acer Therapeutics

Acer Therapeutics is a pharmaceutical company that develops and commercializes therapies for rare and life-threatening diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Newton, MA, USA

total rounds

7

total raised

$116.95M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$21.14M

Money Raised

Their latest funding was raised on 29.03.2023. Their latest investor Karolinska. Their latest round Convertible Note

Date 
Funding Round 
Investors 
Money Raised 
Lead 
29.03.2023
1
$673.48K
Local Amount - SEK 7M
12.05.2022
1
$1.13M
Local Amount - SEK 11.5M
13.07.2018
1
$15.76M
Local Amount - SEK 140M
Karolinska

Karolinska

Karolinska Development invests in medical innovations and supports life science companies.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Medical Device, Life Science, Biotechnology

Location

Solna, Sweden

count Of Investments

26

count Of Exists

3
Karolinska

Karolinska

Karolinska Development invests in medical innovations and supports life science companies.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Medical Device, Life Science, Biotechnology

Location

Solna, Sweden

count Of Investments

26

count Of Exists

3
HealthCap

HealthCap

HealthCap is a venture capital firm that invests in life sciences globally.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Health Care, Venture Capital

Location

Stockholm, Sweden

count Of Investments

96

count Of Exists

14
Co-Investors
Investors
6
4

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Convertible Note, Post-IPO Debt
Yes
Venture - Series Unknown
Yes
Venture - Series Unknown
Karolinska

Karolinska

Karolinska Development invests in medical innovations and supports life science companies.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Medical Device, Life Science, Biotechnology

Location

Solna, Sweden

count Of Investments

26

count Of Exists

3

KDev Investments

KDev Investments

count Of Investments

1
Praktikerinvest

Praktikerinvest

Praktikerinvest is an investment company within the Praktikertjänst Group that offers health care services.

Sector

Health Care Providers

Subsector

Health Care Management Services

Keywords

Health Care

Location

Stockholm, Sweden

count Of Investments

3

count Of Exists

1

People

Founders
1
Mats Wahlgren
Mats Wahlgren

Mats Wahlgren

Professor Mats Wahlgren investigates the molecular pathogenesis of parasitic diseases. Previous positions include directorship of MTC (KI), the Multilateral Initiative on Malaria and the Infection and Vaccinology Programme (SSF). He has been trustee/ committee member of the HIV Research Trust, the Wellcome Trust and World Health Organisation. Professor Wahlgren has received a Fogarty Award, the Harford Visiting Professorship at Washington University, the Söderberg professorship of the Royal Swedish Academy of Sciences and a ’Distinguished Professor Award‘ from Karolinska Institutet. He is a member of the Nobel assembly. Professor Wahlgren is co-founder of Modus Therapeutics and several other biotech companies.

current job

Modus Therapeutics
Modus Therapeutics

organization founded

1

Mats Wahlgren

Employee Profiles
5
Ellen Wittmack Donnelly

Ellen Wittmack Donnelly

CEO

Lena Jendeberg

Lena Jendeberg

Vice President, Development

Mats Wahlgren

Mats Wahlgren

Co-Founder, Chief Scientific Officer

Thomas Knittel

Thomas Knittel

Chief Medical Officer

Activity

Recent News
0